中药结合介入手段治疗肝癌的研究进展  

Research advances in traditional Chinese medicine combined with interventional therapy for hepatocellular carcinoma

作　　者：刘洋[1] 李桂英[1] 赵相轩[1] 卢再鸣[1] 郭启勇[1] 

机构地区：[1]中国医科大学附属盛京医院放射科,沈阳110004

出　　处：《临床肝胆病杂志》2015年第1期118-122,共5页Journal of Clinical Hepatology

基　　金：国家自然科学基金资助项目(31240025);国家自然科学基金面上项目(31371425);辽宁省自然科学基金(2013023056)

摘　　要：介入方式治疗肝癌以创伤小、局部作用明显等优势成为非手术治疗肝癌的首选治疗方式。但因药物疗效、肝癌的生物学特性等原因,其疗效不尽如人意。中药与介入手段结合治疗肝癌的研究越来越受到重视。从治疗方式的角度,回顾了近十年来中药结合介入手段治疗肝癌动物实验及临床研究进展,指出中药结合介入手段治疗原发性肝癌具有独特优势。Interventional therapy has become the first choice of non-surgical treatment for hepatocellular carcinoma （HCC）due to its ad-vantages such as little trauma and marked local effect.However,the clinical efficiency is less than expected.One of the possibilities is the resistance of cancer cells to anti -cancer drugs.Increasing attention has been paid to the combination of traditional Chinese medicine （TCM）and interventional therapy in HCC treatment.This paper reviews the progress in TCM combined with interventional therapy for HCC at animal experiment and clinical study levels in recent ten years.It is pointed out that the combination therapy with TCM and intervention for HCC has a unique advantage.

关 键 词：肝肿瘤 中草药 放射摄影术 介入性 综述 

分 类 号：R735.7[医药卫生—肿瘤]